What is the maximum recommended dosage for atomoxetine (Attention Deficit Hyperactivity Disorder - ADHD) treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dosage for Atomoxetine in ADHD

The maximum daily dose of atomoxetine is 100 mg/day for adults and adolescents over 70 kg, or 1.4 mg/kg/day (whichever is lower) for children and adolescents up to 70 kg. 1

Dosing by Body Weight

Adults and Adolescents Over 70 kg

  • Maximum dose: 100 mg/day 1
  • Initial dose: 40 mg/day 1
  • Target dose: 80 mg/day 1

Children and Adolescents Up to 70 kg

  • Maximum dose: 1.4 mg/kg/day 1
  • Initial dose: 0.5 mg/kg/day 1
  • Target dose: 1.2 mg/kg/day 1

Critical Dosing Considerations

Titration Timeline

  • Start with 40 mg/day in adults and adolescents over 70 kg 2
  • Wait 6-12 weeks to achieve full therapeutic effect, unlike stimulants which work within hours 2
  • Maintain patients on the target dose for 4-6 weeks before judging efficacy 2
  • Increase doses in the smallest available increments at intervals of approximately 1-2 weeks 2

Dose Adjustments Required

Hepatic Impairment: 1

  • Moderate hepatic impairment: Reduce to 50% of normal dose
  • Severe hepatic impairment: Reduce to 25% of normal dose

CYP2D6 Poor Metabolizers or Strong CYP2D6 Inhibitor Use: 1

  • Dose adjustment necessary when using potent CYP2D6 inhibitors (including many SSRIs) 3
  • SSRIs can elevate serum atomoxetine levels through CYP2D6 inhibition, requiring dose reduction 3

Evidence Supporting Maximum Dosing

Dose-Response Studies

  • Research demonstrates that 1.2 mg/kg/day is as effective as 1.8 mg/kg/day in children and adolescents, making 1.2 mg/kg/day the appropriate initial target dose for most patients 4
  • The 1.8 mg/kg/day dose showed no additional benefit over 1.2 mg/kg/day but remained within the safe maximum of 1.4 mg/kg/day for regulatory approval 4
  • Adult studies using 60,90, or 120 mg/day showed efficacy, with the FDA-approved maximum set at 100 mg/day 5, 6

Maintenance Dosing

  • For patients with robust acute response, lower maintenance doses (0.5 mg/kg/day) may retain efficacy while reducing drug exposure 7
  • However, this applies only to patients who first achieved response at higher doses 7

Safety Warnings at Maximum Doses

Black Box Warning: 1

  • Increased risk of suicidal ideation in children and adolescents
  • Monitor closely for suicidality, clinical worsening, and unusual behavioral changes, especially during initial months or at dose changes 3

Cardiovascular Monitoring: 1

  • Monitor blood pressure and heart rate at baseline and regularly during treatment
  • Use caution in patients with hypertension, tachycardia, or cardiovascular disease
  • Atomoxetine should not be used in patients with severe cardiovascular disorders that might deteriorate with increases in heart rate and blood pressure

Hepatotoxicity: 1

  • Discontinue and do not restart if jaundice or laboratory evidence of liver injury develops

Common Pitfall to Avoid

Do not exceed 100 mg/day in adults or 1.4 mg/kg/day in children, even if response seems suboptimal 1. If inadequate response occurs after 6-12 weeks at target doses, consider switching to stimulant medications (which have 70-80% response rates) rather than exceeding maximum atomoxetine doses 3. The target dose of 60-100 mg daily for adults represents the therapeutic range, with 100 mg being the absolute ceiling 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.